English 中文網 漫畫網 愛新聞iNews 翻譯論壇
    中國網站品牌欄目(頻道)
    當前位置: Language Tips> Audio & Video> 新聞播報> Normal Speed News VOA常速

    AIDS: delaying treatment has health and financial costs

    [ 2010-11-26 16:01]     字號 [] [] []  
    免費訂閱30天China Daily雙語新聞手機報:移動用戶編輯短信CD至106580009009

    A new study says delaying treatment for people infected with HIV can have long-term health and financial consequences. The findings add to the debate over when anti-retroviral treatment should begin.

    A growing body of research says starting HIV-infected people on drug treatment sooner is better for the patient. Initially, the drugs were given when a person's CD4 immune cell count fell to 200 or below. By that time, the patent could have full-blown AIDS.

    Now the general recommendation is to start treatment when CD4 counts reach 350 – before the immune system collapses. Despite that recommendation, many people are receiving delayed treatment.

    Looking at the evidence

    Dr. Kelly Gebo – a Johns Hopkins University professor of Epidemiology – is the senior author of the study. Gebo and her team reviewed the medical records of more than 8,000 patients in the United States between 2000 and 2007.

    "So, we actually didn't look at when to start treatment. We looked at when people presented for care. And we found that unfortunately nearly half of people – 43 percent of people – were presenting late for care. And those people cost more over the long run," she says.

    Gebo says the study did not look at why treatment was delayed, but the findings did give a few hints.

    "One of the things anecdotally that we do tend to find," she says, "is that people are hospitalized for a severe opportunistic illness and then sort of follow-up for outpatient care. They may have known they were HIV infected for a long period of time and not come for care just because they didn't feel bad or everything was going well. And then when something catastrophic happens is when they start embarking on care."

    CD4 countdown

    Once a person is infected with HIV, unless treatment is given, there's usually a long but steady decline in CD4 cells. So, symptoms of the disease may not appear right away.

    Gebo says, "Most people have a CD4 count between 800 and 1200. So we say an average of a thousand. And in HIV when we didn't have antiretrovirals the average CD4 count fell by about a hundred cells per year. So we said it was about eight years from infection to development of AIDS. And in general, it was about a 10-year life expectancy. Now, with antiretrovirals, the whole ballgame has changed."

    Earlier treatment with antiretrovirals gives a person a much better chance of avoiding other illnesses besides full-blown AIDS.

    "So clinically we know that people do better," she says, "They have fewer opportunistic illnesses. They seem to have fewer non-traditionally AIDS-related events. So, cardiovascular disease, malignancies, end stage liver disease, end stage renal disease – all appear to be higher in HIV-infected patients. So treatment with antiretrovirals has been shown to slow the progression of some of those."

    And then there are the medical costs

    The average difference - between those receiving treatment early and those who didn't - ranged from about $27,000 to more than $60,000 over the first seven to eight years. Costs are higher for the so-called late presenters because they are often sicker than early presenters.

    "We did look at direct medical costs. And in the direct medical costs, it was certainly cheaper with treating people with antiretrovirals, even given the cost of 10 to 12 thousand dollars a year for antiretrovirals when you look at the reduction in hospitalizations, other medications used and some of the other outpatient utilization and laboratories that we evaluate in our study," she says.

    And earlier treatment allows people to be more productive longer.

    While the study was not done in a developing country, the findings may provide guidance. Some countries in sub-Saharan Africa, for example, are debating whether to start antiretroviral treatment earlier. However, that means spending more on HIV/AIDS at a time when many economies are still reeling from the global recession.

    More details on the study can be found in the December issue of the journal Medical Care.

    (音頻腳本跟音頻會有些許出入,僅供網友參考)

    Related stories:

    AIDS: fewer people being infected, fewer people dying

    Food security, HIV/AIDS treatment and prevention closely linked

    Donors promise 12 billion to fight AIDS, TB and Malaria

    Researchers in South Africa announce a new weapon in AIDS fight

    (來源:VOA 編輯:陳丹妮)

     
    中國日報網英語點津版權說明:凡注明來源為“中國日報網英語點津:XXX(署名)”的原創作品,除與中國日報網簽署英語點津內容授權協議的網站外,其他任何網站或單位未經允許不得非法盜鏈、轉載和使用,違者必究。如需使用,請與010-84883631聯系;凡本網注明“來源:XXX(非英語點津)”的作品,均轉載自其它媒體,目的在于傳播更多信息,其他媒體如需轉載,請與稿件來源方聯系,如產生任何問題與本網無關;本網所發布的歌曲、電影片段,版權歸原作者所有,僅供學習與研究,如果侵權,請提供版權證明,以便盡快刪除。
     

    關注和訂閱

    人氣排行

    翻譯服務

    中國日報網翻譯工作室

    我們提供:媒體、文化、財經法律等專業領域的中英互譯服務
    電話:010-84883468
    郵件:translate@chinadaily.com.cn
     
     
    中文字幕丰满伦子无码| 最近免费中文字幕大全高清大全1| 中文字幕视频免费| 国产亚洲情侣一区二区无码AV| 亚洲国产综合精品中文字幕| 午夜无码中文字幕在线播放| 亚洲AV无码精品色午夜果冻不卡| 欧美乱人伦人妻中文字幕| 911国产免费无码专区| 韩国19禁无遮挡啪啪无码网站| 久久久噜噜噜久久中文字幕色伊伊| 亚洲精品无码国产| 69堂人成无码免费视频果冻传媒| 最近免费中文字幕MV在线视频3| 国产成人午夜无码电影在线观看 | 开心久久婷婷综合中文字幕| 亚洲AV蜜桃永久无码精品| 久久男人Av资源网站无码软件| 中文字幕亚洲无线码a| 亚洲欧美中文字幕| 亚洲最大激情中文字幕| 亚洲中文字幕无码爆乳av中文| 国产精品无码永久免费888| 久久无码人妻一区二区三区| 未满十八18禁止免费无码网站| 成在人线av无码免费高潮喷水| 国产品无码一区二区三区在线| 亚洲中文精品久久久久久不卡| 2021国产毛片无码视频| 国产成人A人亚洲精品无码| 欧洲精品久久久av无码电影| 久久久无码一区二区三区 | 国产精品无码a∨精品| 久久久久无码精品国产| 男人的天堂无码动漫AV| 狠狠躁狠狠躁东京热无码专区| 色综合久久无码中文字幕| 亚洲精品无码久久久久久| 无码伊人66久久大杳蕉网站谷歌| 亚洲AV无码精品色午夜果冻不卡| 玖玖资源站无码专区|